Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer
Clinical trial NCT04941885 · UNKNOWN
Trial details
- NCT number
- NCT04941885
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-07-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.